Sign in
OCEAW Stock Price, Chart, Stats & News
Ocean Biomedical, Inc.
Save
20.40M
Market cap
–
Current P/E
–
Forward P/E
OCEAW chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | 45.18% |
ROA | -852.40% |
ROE | 14.04% |
D/E | -0.10x |
Interest coverage ratio | 0.26x |
OCEAW valuation
P/E | – |
P/S | – |
P/B | -0.00x |
P/CF | -0.00x |
P/FCF | -0.03x |
P/OCF | -0.00x |
PEG | 0.00x |
EV multiple | 0.75x |
About
Ocean Biomedical, Inc. is a biopharmaceutical enterprise primarily engaged in identifying and advancing novel therapeutic agents. Their research and development efforts span several key disease areas, including cancer, fibrotic conditions, infectious illnesses, and inflammatory disorders. The company's current development pipeline features both mono-specific and bi-specific humanized monoclonal antibodies (mAbs).
Similar securities
Based on sector and market capitalization
Report issue